MARKET WIRE NEWS

Time To Sell The BlackRock Capital Allocation Term Trust Despite Its 22.75% Yield

Source: SeekingAlpha

2025-05-20 12:31:56 ET

Summary

  • BCAT's discount to NAV has dramatically narrowed, removing a key catalyst for further upside and making the fund less attractive for discount-driven investors.
  • The sustainability of BCAT's extremely high 22.75% distribution is questionable, increasing the risk of a future distribution cut.
  • A growing allocation to private (Level 3) investments introduces valuation and liquidity risks, which could pressure the discount if distributions outpace returns.
  • With activist catalysts played out and Saba Capital exiting, I rate BCAT a sell, preferring to rotate into funds with larger, unwarranted discounts.

The BlackRock Capital Allocation Term Trust ( BCAT ) is a huge mixed fund with ~$1.6 billion in assets under management while employing a modest ~5% effective leverage. Right now its discount to net asset value has narrowed to 3.31% after significant activist pressure initiated by Saba Capital Management a few years ago. Notwithstanding the extremely high distribution of 22.75% I think it is about time to move on. That doesn’t mean it is a bad fund or it couldn’t be a hold for other investors. My main reason is that I like to switch between funds relatively quickly if they become more or less attractive....

Read the full article on Seeking Alpha

For further details see:

Time To Sell The BlackRock Capital Allocation Term Trust Despite Its 22.75% Yield
BlackRock Capital Allocation Trust of Beneficial Interest

NASDAQ: BCAT

BCAT Trading

-1.37% G/L:

$14.79 Last:

430,182 Volume:

$14.76 Open:

mwn-ir Ad 300

BCAT Latest News

July 24, 2025 07:46:00 pm
Where are the Opportunities in (BCAT)

BCAT Stock Data

$1,621,484,325
87,451,000
0.2%
3
N/A
Asset Management Services
Finance
US
Wilmington

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App